Stroke Trial, Recruiting NCT06155032 Sponsor: First Affiliated Hospital of Wannan Medical College Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06155032
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have had symptoms of an acute ischemic stroke (a stroke caused by a blockage) and your initial stroke severity score was below 6 points
  • Your symptoms got worse within 7 days of your stroke first starting
  • You can be enrolled in the study more than 24 hours after your stroke began (based on the last time you were known to be well)
  • Your symptoms worsened within 24 hours before being enrolled in the study
  • Your stroke severity score was 6 points or higher just before being enrolled
  • You have given your written agreement to take part in the study
  • A scan (CTA or MRA) has confirmed a blockage in a specific major brain artery (the internal carotid artery or the main branch of the middle cerebral artery)
  • Your worsening symptoms are linked to reduced blood flow in the same area of the brain affected by your stroke
  • A brain scan score (called ASPECTS) shows your brain tissue is mostly still healthy (score of 6 or above)
  • A special blood flow scan shows there is a salvageable area of brain at risk, with a small core of damage (less than 50ml), and a significant mismatch between damaged and at-risk tissue (confirm with trial site for full details)

Who may not be able to join:

  • You had significant disability before your stroke (confirm with trial site)
  • Scans show your symptoms are caused by bleeding in the brain, brain swelling, or another clear non-blockage cause
  • There are physical features of your blood vessel that may make it too difficult or risky to perform the procedure (such as the vessel being too narrow, too twisty, or hard to reach)
  • Multiple blood vessels are severely narrowed or blocked
  • You have an untreated brain aneurysm, a brain tumour (except small, low-risk meningiomas), or an abnormal tangle of blood vessels in the brain
  • You have had any bleeding in the brain in the past 6 months
  • You have had bleeding in your stomach or urinary system, a heart attack, a head injury, or major surgery in the past month
  • You have a known tendency to bleed — for example, very low platelet levels or you are taking blood thinners with levels outside a safe range
  • You have severe heart, liver, or kidney problems, or another serious advanced illness
  • You have a known allergy to iodine contrast dye or other treatment-related medicines, or a severe allergic reaction to contrast dye that cannot be controlled with medication
  • Your blood pressure is very high and cannot be brought under control (consistently above 185/110 mmHg)
  • Your blood sugar levels are dangerously low or very high (below 2.8 mmol/L or above 22.2 mmol/L)
  • You are pregnant, or you are a woman of childbearing age with a positive pregnancy test
  • Your expected survival is less than 1 year due to another serious condition such as cancer or severe heart or lung disease
  • You are already taking part in another interventional clinical trial that could affect the results of this study
  • You have a mental health, cognitive, or emotional condition that would make it difficult to understand or follow the study procedures, or the investigator has another reason they feel participation would not be appropriate or safe for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Wannan Medical College
Registry
ClinicalTrials.gov
Start date
4 January 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

90-day good clinical outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov